Biogen Shares Crater After CMS Limits Coverage For Alzheimer's Drug

The news caused Biogen shares to crater in after-hours trade, as shares sunk 7%.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.